Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: May 2026 and Sep 2026.
- Largest single sale: $944K (14,000 shares) of Travere Therapeutics, Inc. on Sep 10, 2026. Filing
- Last sale before this period: Sep 30, 2024.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | Director | Oct 10, 2014 | Sep 11, 2026 |
Recent filings
The last 3 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 10, 2026, Travere Therapeutics, Inc.: sold 20,000 shares for $1.3M, under a disclosed plan; 20,000 shares acquired by exercising options. 1 filing: 1
- May 19, 2026, Travere Therapeutics, Inc.: 4,000 shares awarded. 1 filing: 1
- May 4, 2026, Travere Therapeutics, Inc.: sold 8,000 shares for $360K, under a disclosed plan; 8,000 shares acquired by exercising options. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.